Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OCTOPUS trial in hypertensive chronic hemodialysis patients
ACTRN12609000838213Phase 4Active, not recruiting
- Sponsor
- Kinitoshi Iseki
- Start
- Jun 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of olmesartan in resistant hypertension (RH) (2 arms), sponsored by Kinitoshi Iseki. Primary endpoints: All-cause mortality, New onset cardiovascular disease, stroke, and congestive heart failure requiring hospitalization and 1 more. Started Jun 2006; status: active, not recruiting.
02
Drugs
olmesartan
03
Conditions
resistant hypertension (RH)
Beyond the preview
Go deeper on ACTRN12609000838213.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12609000838213.